Domain EYEION.com for sale! This premium domain is available now at Kadomain.com

When hospitals and insurers fight, patients get caught in the middle

  • medicalxpress.com language
  • 2025-09-08 18:20 event
  • 1 week ago schedule
When hospitals and insurers fight, patients get caught in the middle
Amy Frank said it took 17 hours on the phone over nearly three weeks, bouncing between her insurer and her local hospital system, to make sure her plan would cover her husband's post-surgery care.

814. He built Michigan's Medicaid work requirement system: Now he's warning other states

  • 1 week ago schedule
  • medicalxpress.com language

It was March 2020, and Robert Gordon was about to kick some 80,000 people off health insurance.

815. First 'perovskite camera' can see inside the human body

  • 1 week ago schedule
  • medicalxpress.com language

Physicians rely on nuclear medicine scans, like SPECT scans, to watch the heart pump, track blood flow and detect diseases hidden deep inside the body. But today's scanners depend on expensive detectors that are difficult to make.

816. Women and older adults are driving sales of creatine higher

  • 1 week ago schedule
  • medicalxpress.com language

Creatine is shedding its gym-bro reputation, unlocking lucrative new markets as women and older Americans get wise to the benefits of the long-stigmatized supplement. Sales are booming as a result.

817. Vaccine chaos: Even some vulnerable seniors can't get COVID shots amid spiking cases

  • 1 week ago schedule
  • medicalxpress.com language

Seniors in some parts of the country say they are being denied COVID-19 vaccinations amid an ongoing spike in cases, leading to rising frustration over new Trump administration policies that are making it harder to get the shots.

818. Pediatrician explains the effects of caffeine on kids

  • 1 week ago schedule
  • medicalxpress.com language

A cup of coffee or tea in the morning or an afternoon caffeine pick-me-up is usually fine for most adults. But parents might want to take a closer look at caffeine and other ingredients in the drinks their kids love.

819. Is multicancer testing valuable? Questions to ask before getting screened

  • 1 week ago schedule
  • medicalxpress.com language

For doctors and patients, the Holy Grail of medicine would be a simple blood or saliva test to detect all types of cancer before symptoms or sickness appears. Doctors could screen and treat patients earlier in the course of disease. As Dr. Lisa Stempel, director of the high-risk cancer screening program at Rush University Medical Center, told the Tribune recently, "The goal of all screening is to find cancer early when we can treat it."

820. FDA creates 'green list' of GLP-1 drug ingredients approved for entry in the U.S.

  • 1 week ago schedule
  • medicalxpress.com language

The U.S. Food and Drug Administration has created a "green list" import alert to stop unapproved and unverified glucagon-like peptide 1 (GLP-1) drug ingredients from entering the United States.

821. As insurers struggle with GLP-1 drug costs, some seek to wean patients off

  • 1 week ago schedule
  • medicalxpress.com language

After losing 50 pounds on the injectable weight loss medication Zepbound, Kyra Wensley received a surprising letter from her pharmacy benefit manager in April.

822. Substance use during pregnancy can harm a fetus, experts warn

  • 1 week ago schedule
  • medicalxpress.com language

Using alcohol, tobacco, marijuana or other substances during pregnancy can harm the developing fetus, even when the risks are not always obvious, a West Virginia University psychiatrist warns.

823. When hospitals and insurers fight, patients get caught in the middle

  • 1 week ago schedule
  • medicalxpress.com language

Amy Frank said it took 17 hours on the phone over nearly three weeks, bouncing between her insurer and her local hospital system, to make sure her plan would cover her husband's post-surgery care.

824. Clinical trial suggests benefit of adjuvant chemo-immunotherapy in resected stage IB–IIIA NSCLC

  • 1 week ago schedule
  • medicalxpress.com language

Interim results from the NADIM ADJUVANT Phase III trial, led by the Spanish Lung Cancer Group (GECP), suggest that adjuvant chemo-immunotherapy may reduce the risk of recurrence in patients with completely resected stage IB–IIIA non-small cell lung cancer (NSCLC) while maintaining an acceptable safety profile.

825. No OS benefit for concurrent and consolidative durvalumab vs. consolidation alone in unresectable stage 3 NSCLC: Trial

  • 1 week ago schedule
  • medicalxpress.com language

Treating patients who have stage III non-small cell lung cancer (NSCLC) with durvalumab concurrent with chemoradiotherapy (CRT) and continuing as consolidation therapy did not improve overall survival compared to consolidation durvalumab alone, according to research presented at the International Association for the Study of Lung Cancer (IASLC) 2025 World Conference on Lung Cancer (WCLC).

826. FDA warns of juice recall linked to potential foodborne illness

  • 1 week ago schedule
  • medicalxpress.com language

Parents in New Jersey, Pennsylvania and New York may want to pause before they pack a juice drink in their child's lunchbox.

827. BMS-986504 demonstrates durable responses in MTAP-deleted NSCLC, including EGFR and ALK-positive tumors

  • 2 weeks ago schedule
  • medicalxpress.com language

BMS-986504, a first-in-class methylthioadenosine (MTA)-cooperative protein arginine methyltransferase 5 (PRMT5) targeting agent, showed promising antitumor activity in heavily pretreated patients with MTAP-deleted non-small cell lung cancer (NSCLC), according to results from the Phase I CA240-0007 trial presented at the International Association for the Study of Lung Cancer 2025 World Conference on Lung Cancer (WCLC).

828. Lung cancer screening benefits adults up to age 80 if surgical candidates, UK study finds

  • 2 weeks ago schedule
  • medicalxpress.com language

Older individuals between the ages of 75 and 80 who are eligible for lung surgery may achieve survival outcomes comparable to younger patients following lung cancer screening, according to research presented today at the International Association for the Study of Lung Cancer World Conference on Lung Cancer (WCLC 2025) held in Barcelona.

829. Video-assisted thoracoscopy surgery reduces mortality by 21% compared to lobectomy, meta-analysis suggests

  • 2 weeks ago schedule
  • medicalxpress.com language

Patients who underwent video-assisted thoracoscopic surgery (VATS) compared to open lobectomy had a significantly improved overall survival rate, according to a meta-analysis presented at the International Association for the Study of Lung Cancer (IASLC) 2025 World Conference on Lung Cancer (WCLC).

830. Hypofractionated radiotherapy with chemotherapy offers comparable survival, lower toxicity in LS-SCLC

  • 2 weeks ago schedule
  • medicalxpress.com language

A multi-center, randomized phase III trial has found that a three-week hypofractionated radiotherapy (HypoRT) schedule with concurrent chemotherapy provides similar survival outcomes and reduced toxicity compared to the standard six-week conventional fractionated radiotherapy (ConvRT) schedule for patients with limited-stage small cell lung cancer (LS-SCLC).

831. Florida's plan to drop school vaccine rule won't start for 90 days, won't cover all diseases

  • 2 weeks ago schedule
  • medicalxpress.com language

Florida's plan to drop school vaccine mandates likely won't take effect for 90 days and would include only chickenpox and a few other illnesses unless lawmakers decide to extend it to other diseases, like polio and measles, the health department said Sunday.

832. Are patients undergoing surgery for early-stage cancer at risk of persistent opioid use?

  • 2 weeks ago schedule
  • medicalxpress.com language

New research indicates that many patients who undergo surgery with the intent to cure early‐stage cancer continue or start opioid prescriptions in the year following surgery. The findings are published in Cancer.

Cookie Policy

We use cookies and similar technologies to help the site provide a better user experience. By using the website you agree to our Cookie Policy, Terms of Use and Privacy Policy.